Barbara G. W.
- Country
- Poland
- Department
- FutureMeds Kraków
Research Overview
- Evaluation of GS-0151 in Patients With Rheumatoid Arthritis: A Clinical Trial
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
- Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Compared to Denosumab in Post-Menopausal Osteoporosis Patients
Data & Insights
Has run more than one trial at 150 of 268 partner sites.
Specializations
Bone Health Specialization
The investigator demonstrates significant expertise in postmenopausal osteoporosis and conditions affecting bone mineral density. Their research encompasses innovative therapeutic approaches for managing bone mass loss in postmenopausal women.
- Postmenopausal bone health management
- Bone density assessment and monitoring
- Osteoporosis therapeutics
Rheumatology Focus
A key area of the investigator's research involves psoriatic arthritis treatment, particularly exploring new therapeutic options for patients who haven't previously received biological disease-modifying antirheumatic drugs.
- Inflammatory joint conditions
- Biologic therapy assessment
- Autoimmune disorders
Therapeutic Development
The investigator's work extends to evaluating biosimilar medications and novel therapeutic agents, with particular attention to their pharmacodynamic profiles and clinical efficacy in treating bone disorders.
- Biosimilar evaluation
- Bone marker analysis
- Therapeutic equivalence studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.